Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Abstract Background We aimed to develop a radiomic model based on pre-treatment computed tomography (CT) to predict the pathological complete response (pCR) in patients with rectal cancer after neoadjuvant treatment and tried to integrate our model with magnetic resonance imaging (MRI)-based radiomi...

Full description

Bibliographic Details
Main Authors: Zhuokai Zhuang, Zongchao Liu, Juan Li, Xiaolin Wang, Peiyi Xie, Fei Xiong, Jiancong Hu, Xiaochun Meng, Meijin Huang, Yanhong Deng, Ping Lan, Huichuan Yu, Yanxin Luo
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Translational Medicine
Subjects:
Radiomics
Computed tomography
Neoadjuvant treatment
Rectal cancer
Online Access:https://doi.org/10.1186/s12967-021-02919-x

Internet

https://doi.org/10.1186/s12967-021-02919-x

Similar Items